-
Home
-
Product
-
IMMUNOHISTOCHEMISTRY
-
INSTRUMENT
-
MOLECULAR
-
HISTOLOGY
-
CYTOLOGY
-
DIGITAL PATHOLOGY
-
-
Solution
-
Support
-
About
-
Contact
PRODUCT CATEGORY
PRODUCT CATEGORY
CONTACT US
Phone
Email
Address
ZhengZhou (HQ), Shenzhen (R&D Center), Suzhou (R&D Center), China
AML/ETO Gene Fusion Detection Kit
Clinic Signification：
1.20-40% of patients with AML-M2 have t (8; 21) (q22; q22), and the incidence rate is more than 90% in the M2b subtype, which is relatively rare in M1 and M4.
2.It is most often diagnosed in youth and children.
3.Mark for M2b classification and excellent prognosis.
Chat
message
Quote
Contrast
AML/ETO Negative
AML/ETO Positive
More Info
Probe Description: AML/ETO
Cat.No.: CF1120
Specification: 10 tests/box, 20 tests/box
Related Product
